Related Experiment Videos
[The utility of high density lipoprotein cholesterol subclasses measurement]
Anna Skoczyńska1, Barbara Turczyn, Małgorzata Kuliszkiewicz-Janus
1Katedra i Klinika Chorób Wewnetrznych, Zawodowych i Nadciśnienia Tetniczego AM we Wrocławiu.
Insights
This study investigated high-density lipoprotein (HDL) subfractions in patients with normal cholesterol but with coronary artery disease or myeloproliferative diseases, finding lower HDL cholesterol and increased lipid peroxidation in both groups.
Area of Science:
- Biochemistry
- Cardiovascular Medicine
- Hematology
Context:
- High-density lipoprotein (HDL) cholesterol levels are typically associated with cardiovascular risk.
- Atherosclerosis and myeloproliferative diseases often present with altered lipid profiles, including abnormal HDL levels.
- Investigating HDL subfractions (HDL2 and HDL3) in normocholesterolemic patients provides insight into lipoprotein metabolism independent of overall cholesterol levels.
Purpose:
- To determine cholesterol concentrations in HDL2 and HDL3 subfractions.
- To analyze HDL subfraction metabolism in patients with coronary artery atherosclerosis and myeloproliferative diseases, despite normal plasma cholesterol.
- To understand HDL metabolism changes independent of other lipoprotein cholesterol levels.
Summary:
- In normocholesterolemic patients with coronary artery atherosclerosis, a reduction in HDL2 and HDL3 cholesterol was observed.
- Normocholesterolemic patients with myeloproliferative diseases showed a slight decrease in HDL3 cholesterol, potentially linked to hypertriglyceridemia.
- Both patient groups exhibited decreased HDL cholesterol accompanied by increased lipid peroxidation.
Impact:
- Findings suggest that reduced HDL cholesterol and elevated lipid peroxidation in HDL subfractions may be independent risk factors or indicators in specific disease states.
- This research highlights the importance of analyzing HDL subfractions for a nuanced understanding of cardiovascular and hematological disorders.
- The study contributes to understanding lipoprotein dysmetabolism in conditions not typically characterized by hypercholesterolemia.
Abstract:
The aim of our study was to estimate the cholesterol concentrations in high density lipoprotein subfractions (HDL2 i HDL3) in plasma of patients with normocholesterolemia and atherosclerosis of coronary arteries and in patients with myeloproliferative diseases. Blood samples from patients with normal plasma cholesterol levels were analyzed in spite of the fact that atherosclerosis of coronary arteries usually exist with hypercholesterolemia and myeloproliferative diseases usually coexist with hypocholesterolemia. In this way we wanted to determine changes in HDL2 i HDL3 metabolism which occur independently from changes of cholesterol levels in other lipoproteins. Our results showed that in patients suffering from atherosclerosis of coronary arteries with normolipemia the lowering of plasma cholesterol level in subfractions HDL2 and HDL3 was observed. In patients with myeloproliferative disease with normocholesterolemia the slight lowering of cholesterol level in subfraction HDL3 may be connected with moderate hypertriglyceridemia. In both groups of patients the lowering of HDL cholesterol in plasma was accompanied with the increased lipid peroxidation.